Drug Trials Snapshots: KISUNLA
Summary
Drug Trials Snapshots: KISUNLA is an amyloid beta-directed antibody used to treat people with Alzheimer’s disease. Alzheimer’s disease is a common degenerative disease of the brain that starts with mild thinking, judging, and memory problems and progresses to dementia and death.
Description
Drug Trials Snapshots: KISUNLA is an amyloid beta-directed antibody used to treat people with Alzheimer’s disease. Alzheimer’s disease is a common degenerative disease of the brain that starts with mild thinking, judging, and memory problems and progresses to dementia and death.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source